<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T05:59:40Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2117/346625" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2117/346625</identifier><datestamp>2025-07-16T22:32:18Z</datestamp><setSpec>com_2072_1033</setSpec><setSpec>col_2072_452949</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Multiplex network uncovers chronic obstructive pulmonary disease endotypes</dc:title>
   <dc:creator>Olvera, Núria</dc:creator>
   <dc:creator>Faner, Rosa</dc:creator>
   <dc:creator>Valencia, Alfonso</dc:creator>
   <dc:subject>Àrees temàtiques de la UPC::Informàtica::Arquitectura de computadors</dc:subject>
   <dc:subject>High performance computing</dc:subject>
   <dc:subject>COPD</dc:subject>
   <dc:subject>network medicine</dc:subject>
   <dc:subject>multi-omics</dc:subject>
   <dc:subject>multiplex networks</dc:subject>
   <dc:subject>Càlcul intensiu (Informàtica)</dc:subject>
   <dcterms:abstract>Chronic Obstructive Pulmonary Disease (COPD) was the&#xd;
fourth leading cause of death in the world in 2019, and its&#xd;
burden is projected to increase in coming decades in relation&#xd;
to the aging of the population [1]. COPD is characterized&#xd;
by persistent respiratory symptoms and airflow limitation.&#xd;
According to the the level of airflow limitation (FEV1 %&#xd;
ref.), patients are classified into four categories (GOLD groups,&#xd;
Fig.1). Nevertheless, airflow severity is only one component of&#xd;
COPD, as patients with the same level of airflow limitation can&#xd;
present different symptoms, comorbidities and pathological&#xd;
processes (i.e. emphysema, cardiovascular diseases, cachexia,&#xd;
neutrophilic/eosinophilic inflammation) [2]. As a result, COPD&#xd;
is currently viewed as a heterogeneous disease with several&#xd;
endotypes, which are the molecular mechanisms leading to the&#xd;
clinical phenotype of the disease. Recognition of this disease&#xd;
heterogeneity is important as different endo-phenotypes may&#xd;
respond differently to therapies, so that more personalized&#xd;
therapies could be applied.&#xd;
The main objective of this work is to understand the&#xd;
local and molecular heterogeneity of the disease integrating&#xd;
different types of genomic data which are known to play a&#xd;
role in the pathology. We jointly profiled the mRNA, miRNA&#xd;
and methylome in lung tissue from 135 individuals with&#xd;
different grades of disease severity. In order to integrate all&#xd;
the diversified data, a multiplex patient similarity network was&#xd;
built and communities were detected through unsupervised&#xd;
clustering. Then, these clusters of patients were characterized&#xd;
using the clinical and genetic data available.</dcterms:abstract>
   <dcterms:issued>2021-05</dcterms:issued>
   <dc:type>Conference report</dc:type>
   <dc:rights>Open Access</dc:rights>
   <dc:publisher>Barcelona Supercomputing Center</dc:publisher>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>